INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 97 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $50,000 | -52.4% | 43,459 | -6.6% | 0.00% | -100.0% |
Q4 2021 | $105,000 | -36.0% | 46,518 | -2.9% | 0.00% | 0.0% |
Q3 2021 | $164,000 | +11.6% | 47,910 | -2.3% | 0.00% | – |
Q2 2021 | $147,000 | +50.0% | 49,048 | +62.2% | 0.00% | – |
Q1 2017 | $98,000 | +157.9% | 30,248 | +7.1% | 0.00% | – |
Q4 2016 | $38,000 | -99.9% | 28,249 | -0.3% | 0.00% | – |
Q3 2016 | $44,184,000 | +17.5% | 28,323 | +0.2% | 0.00% | – |
Q2 2016 | $37,612,000 | -75.1% | 28,280 | -1.5% | 0.00% | -100.0% |
Q1 2016 | $151,000,000 | -32.9% | 28,723 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $225,000,000 | +92492.6% | 28,723 | -0.2% | 0.00% | 0.0% |
Q3 2015 | $243,000 | -99.9% | 28,773 | +0.1% | 0.00% | 0.0% |
Q2 2015 | $314,692,000 | -26.3% | 28,739 | -5.8% | 0.00% | -50.0% |
Q1 2015 | $426,712,000 | -17.2% | 30,523 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $515,533,000 | +21.1% | 30,523 | -3.8% | 0.00% | 0.0% |
Q3 2014 | $425,817,000 | +5.3% | 31,730 | -0.1% | 0.00% | 0.0% |
Q2 2014 | $404,546,000 | +4.5% | 31,754 | -2.5% | 0.00% | 0.0% |
Q1 2014 | $387,091,000 | -11.8% | 32,556 | +2.5% | 0.00% | 0.0% |
Q4 2013 | $438,799,000 | -21.6% | 31,774 | -1.0% | 0.00% | -33.3% |
Q3 2013 | $560,023,000 | +67.8% | 32,093 | +56.2% | 0.00% | +50.0% |
Q2 2013 | $333,808,000 | – | 20,542 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,354,963 | $38,132,000 | 1.80% |
Orbimed Advisors | 4,520,800 | $73,201,000 | 1.55% |
QVT Financial LP | 1,326,610 | $21,480,000 | 1.44% |
BB BIOTECH AG | 1,089,828 | $17,646,000 | 1.27% |
Meditor Group Ltd | 250,000 | $4,048,000 | 0.55% |
Perimeter Capital Partners, LLC | 159,915 | $2,589,000 | 0.50% |
EMERALD MUTUAL FUND ADVISERS TRUST | 156,808 | $2,539,000 | 0.43% |
Broadfin Capital, LLC | 117,172 | $1,897,000 | 0.37% |
OXFORD ASSET MANAGEMENT LLP | 811,331 | $13,184,000 | 0.36% |
Baker Brothers Advisors | 1,016,433 | $16,458,000 | 0.33% |